Главная > События >Mexican Ulsatech Oncology Production Line Project Sharing

Mexican Ulsatech Oncology Production Line Project Sharing

www.6662016.com www.sparta-cuss.com Tofflon Institute Recommendation

In 2014  Tofflon successfully won the Oncology  Production Line Project  from Mexican Ulsatech.  All the critical  technology and  equipments are  from Tofflon, which includes Auto Solution Preparation Systems, Vial Filling Line, Freeze dryer, Auto Loading Systems, Isolator, External Washing Machine and  Intelligent Vision Systems.   

This is the first oncology  production line  project in Mexico,  even a remarkable project  all over  Latin America. This  oncology production line’s  design, manufacturing and qualification  are  executed  as per US FDA  and  EU GMP guidelines. The oncology products’ OEB level is OEB 5,  so  the production line shall offer protection for the products as well as protection for the personnel. Tofflon freeze drying system offers an integrated solution from  technical design, project management and validation support. This project case study shares with you our latest technology and best practice in freeze drying system for the oncology products. 

Tofflon Scope of Supply   

  • 1 set of Auto Solution Preparation Systems   
  • 1 set of 100VPM Vial Filling Line, including: Washing Machine, Sterilization Tunnel, Filling Machine, Capping Machine and External Washing Machine 
  • 2 x Freeze Dryers:LYO-10(SIP,CIP) + LYO-5(SIP,CIP) 
  • 2 x Fixed (Row-by-Row) Auto Loading Systems 
  • 1 set of Isolators  for Filling Machine, Row-by-Row, Capping Machine, External Washing Machine 
  • 1 set of API Dispensing Isolator for Auto Solution Preparation Systems 
  • 1 set of  Intelligent Vision Systems for  liquid vials and  lyophilized  vials auto inspection 

In this project, Tofflon Freeze Drying System offers integrated solution. Upstream and downstream equipments can be well  integrated which much reduces  the complicated interfaces risk from  different  vendors machines. Meanwhile  the whole facility can be well tested and qualified as one complete module to ensure each machine’s capacity can match each other so as to avoid possible machine’s down and idle time.   

 “T” layout design can meet both liquid vials and lyophilized vials production. The buffer turntable can shunt the liquid vials and lyophilized vials production flow. 

Clean  room adopts the visible glass wall. It offers comfortable visualization  for  visitor and inspectors.   

Control system: English and Spanish version can be chosen. It greatly makes the whole operation and maintenance job more friendly and convenient for local operator.    

Central Monitoring System allows  facility supervisor check all machines running status  in one system. If there is any alarm, machine breakdown  or operator’s incorrect operation, this system can easily display and record the event. It can achieve  central monitoring, central traceability and  central problem  analysis. 

Siemens PLC modular is adopted for each individual equipment communication on the uniform  platform to increase the efficiency and  to  reduce the programming time.   

Central deactivation and individual deactivation  design: Each toxic liquid leakage point can be individually deactivated by spraying deactivation liquid and neutralization liquid or the operator can collect all the toxic liquid to the central deactivation system for final deactivation.

Part 1: Company Introduction 

Ulsatech SA DE CV is a Mexican company located in Guadalajala City. The plant is spread over an area of 2,000 square meters, with a built up area of  over 5,000  square meters.  The equipments, utilities, plant and machinery meet the international standards. It has a well-equipped analytical and microbial testing facility. The manufacturing  facility  works for  the highest possible quality standards of Mexican, US and European standards.  

Part 2: Project Introduction     

Its annual capacity is 20 million vials. As the first Mexican  oncology plant, it breaks through  multinational pharma companies’  monopoly on high value oncology drugs.   The products  are not only sold in Mexican market, but also exported to Middle American countries and North American markets.   Therefore all the facility shall meet Mexican and international standards. Considering high toxic level, so  the facility’s deactivation and  isolation will be validated  by the professional US company.    

Part 3: Key Technology  

1. Auto Solution Preparation Systems    

2. Vial Filling Line

3.  Isolator  

4.  Freeze Drying System

5.  Intelligent Vision Systems

We believe that “Automation, Isolation, Continuous Processing and Systems Integration” are becoming main stream for aseptic processing of lyophilized injectables. Mexican Ulsatech Oncology Production Line shares our latest technology  and  our recent  best practice under  this  technical  concept. We do hope it offers valuable information for your cGMP practice.